Icon Posts Strong Quarter 2 Results

Icon have announced that they have reviewed their guidance for revenues and earnings per share in fiscal year (FY) 2013 after posting another strong financial quarter. Earlier this week, Icon reported net revenues for their second quarter of US $334.2 million, an increase of 20.6% year on year, comfortably passing the forecast of US $321.8

Continue Reading

Eli Lilly Reveals Strong Q2 Results

Eli Lilly yesterday posted a strong set of financials for the second quarter of 2013, and announced that they would be raising their forecast for the full-year.  The Q2 results were aided by cost-cutting and strong sales of their blockbuster drug, Cymbalta. Net income soared by 36% to $1.25 billion, while turnover increased 6% to

Continue Reading

J&J Report Strong Second Quarter Results

Johnson & Johnson have reported strong results for their second quarter of 2013, with an 8.5% increase in sales.  The increase was aided by robust results from their prostate cancer drug, Zytiga. Net income reached $3.83 billion, a major increase from the $1.41 billion from the previous year’s quarter 2 period, aided by the gain

Continue Reading

AstraZeneca announces new Cambridge Biomedical Campus

Pharmaceutical giant AstraZeneca has announced it is setting up its new global headquarters, just south of Cambridge. The £330million research and development site will employ a skilled workforce of 2,000 people and will open by 2016. Research and Development will cease at Alderley Park in Cheshire and close its London headquarters. Many of these posts will

Continue Reading

If 8 areas of NHS activity were improved then vast amounts of money for CCGS could be saved

If the National Health Service improved just 8 areas of their activity then 212 of England’s Clinical Commissioning Groups (CCGs) would save more than £1.6 billion. Statistics were analysed in research by consultancy MedeAnalytics. This covers all patient-level activity and associated costs taking place in hospitals in England. From analysis, researchers have narrowed down 8

Continue Reading

Icon Release Strong Q1 Results

Icon continued their run of solid quarterly results, reporting an operating income of US $23.0 million, an increase of 96.0% year on year.  Net revenues were also higher, at US $316.8 million. The income total included reorganisation, and other items amounting to US $4.41 million.  Without these charges operating income was up to US $27.4

Continue Reading